Cargando…
Intravenous versus oral iron supplementation for correction of post-transplant anaemia in renal transplant patients
BACKGROUND: Post-transplant anaemia remains a common problem after kidney transplantation, with an incidence ranging from nearly 80% at day 0 to about 25% at 1 year. It has been associated with poor graft outcome, and recently has also been shown to be associated with increased mortality. Our transp...
Autores principales: | Mudge, David W, Tan, Ken-Soon, Miles, Rhianna, Johnson, David W, Campbell, Scott B, Hawley, Carmel M, Isbel, Nicole M, Van Eps, Carolyn L, Nicol, David L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | inglés |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701932/ https://www.ncbi.nlm.nih.gov/pubmed/19500381 http://dx.doi.org/10.1186/1471-2369-10-14 |
Ejemplares similares
-
Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial)
por: Barraclough, Katherine A, et al.
Publicado: (2009) -
Adiponectin is associated with cardiovascular disease in male renal transplant recipients: baseline results from the LANDMARK 2 study
por: Kaisar, Mohd O, et al.
Publicado: (2009) -
Do aluminium-based phosphate binders continue to have a role in contemporary nephrology practice?
por: Mudge, David W, et al.
Publicado: (2011) -
Rationale and design of the HEALTHY-CATH trial: A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients
por: Broom, Jennifer K, et al.
Publicado: (2009) -
Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: a randomized controlled trial
por: Johnson, David Wayne, et al.
Publicado: (2008)